B. , R. Du, and G. , 44 a) Tableau récaptilatif des propositions individuelles 44 b) Tableau récapitulatif après votes individuels45 c) Analyse des votes, ., p.46

V. , D. , A. Revue-de, and L. , 47 a) Guideline français, 47 b) Les recommandations européennes....... 47 c) Les recommandations internationales, p.47

K. Fock, N. Talley, P. Moayyedi, R. Hunt, T. Azuma et al., Asia???Pacific consensus guidelines on gastric cancer prevention, Journal of Gastroenterology and Hepatology, vol.19, issue.2, pp.351-65, 2008.
DOI : 10.1016/j.bpg.2006.11.001

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2008.05314.x/pdf

M. Derakhshan, R. Malekzadeh, H. Watabe, A. Yazdanbod, V. Fyfe et al., Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer, Gut, vol.57, issue.3, pp.298-305, 2008.
DOI : 10.1136/gut.2007.137364

E. Kuipers, G. Nelis, E. Klinkenberg-knol, P. Snel, D. Goldfain et al., Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial Current concepts in the management of Helicobacter pylori infection: Maastrischt III Consensus report, 12?20. 15. Malfertheiner P1, pp.772-81, 2004.

C. Wu, K. Kuo, M. Wu, Y. Chen, C. Wang et al., Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease, Gastroenterology, vol.137, issue.5, pp.1641-1649, 2009.
DOI : 10.1053/j.gastro.2009.07.060

J. Hansen, M. Wildner-christensen, J. Hallas, and O. Schaffalitzky-de-muckadell, Effect of a Community Screening for Helicobacter pylori: A 5-Yr Follow-Up Study, The American Journal of Gastroenterology, vol.316, issue.5, pp.1106-1119, 2008.
DOI : 10.1053/j.gastro.2005.07.028

K. Fukase, M. Kato, S. Kikuchi, K. Inoue, N. Uemura et al., Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, The Lancet, vol.372, issue.9636, pp.392-399, 2008.
DOI : 10.1016/S0140-6736(08)61159-9

B. Schenk, E. Kuipers, G. Nelis, E. Bloemena, J. Thijs et al., Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy, Gut, vol.46, issue.5, pp.615-636, 2000.
DOI : 10.1136/gut.46.5.615

R. Stasi, A. Sarpatwari, J. Segal, J. Osborn, M. Evangelista et al., Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review, Blood, vol.113, issue.6, pp.1231-1271, 2009.
DOI : 10.1182/blood-2008-07-167155

G. Papatheodoridis, S. Sougioultzis, and A. Archimandritis, Effects of Helicobacter pylori and Nonsteroidal Anti-Inflammatory Drugs on Peptic Ulcer Disease: A Systematic Review, Clinical Gastroenterology and Hepatology, vol.4, issue.2, pp.130-172, 2006.
DOI : 10.1016/j.cgh.2005.10.006

L. Anderson, S. Murphy, B. Johnston, R. Watson, H. Ferguson et al., Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study, Gut, vol.57, issue.6, pp.734-743, 2008.
DOI : 10.1136/gut.2007.132662

G. Papatheodoridis and A. Archimandritis, eradication in aspirin or non-steroidal anti-inflammatory drug users, World Journal of Gastroenterology, vol.11, issue.25, pp.3811-3817, 2005.
DOI : 10.1053/gast.2002.36013

J. Huang, S. Sridhar, and R. Hunt, Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

L. Schistosomes, . Flukes, and . Helicobacter-pylori, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monogr Eval Carcinog Risks Hum World Health Organ Int Agency Res Cancer, vol.61, pp.1-241, 1994.

G. Gatta, T. Hakulinen, A. Micheli, M. ;. Sant, and A. Verdecchia, Survival of cancer patients in Europe: the EUROCARE-2 Study, IARC Sci Publ, vol.151, 1999.

N. Vakil, B. Traxler, and D. Levine, Symptom Response and Healing of Erosive Esophagitis with Proton-Pump Inhibitors in Patients with Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.115, issue.1, pp.1437-1478, 2004.
DOI : 10.1111/j.1572-0241.2001.05263.x

A. Raghunath, A. Hungin, D. Wooff, and S. Childs, The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis, Alimentary Pharmacology and Therapeutics, vol.16, issue.1, pp.733-777, 2004.
DOI : 10.1046/j.1365-2036.2002.01169.x

C. Fallone, A. Barkun, S. Mayrand, G. Wakil, G. Friedman et al., There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori, Alimentary Pharmacology and Therapeutics, vol.45, issue.1, pp.761-769, 2004.
DOI : 10.1007/BF00191963

Y. Niv, G. Niv, and R. Koren, 13C-Urea Breath Test for Diagnosis of Helicobacter pylori Infection in the Elderly, Digestive Diseases and Sciences, vol.110, issue.Suppl 1, pp.11-121840, 2004.
DOI : 10.1007/s10620-004-9581-4

P. Moayyedi, J. Deeks, N. Talley, B. Delaney, and D. Forman, An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews, The American Journal of Gastroenterology, vol.136, issue.2, pp.2621-2627, 2003.
DOI : 10.1136/gut.48.6.759

E. Kuipers, L. Lundell, E. Klinkenberg-knol, N. Havu, F. Hp et al., Infection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication, New England Journal of Medicine, vol.334, issue.16, pp.1018-1040, 1996.
DOI : 10.1056/NEJM199604183341603

L. Lundell, N. Havu, P. Miettinen, H. Myrvold, L. Wallin et al., Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial, Alimentary Pharmacology and Therapeutics, vol.89, issue.186, pp.639-686, 2006.
DOI : 10.1080/00365520410003362

P. Moayyedi, C. Wason, R. Peacock, A. Walan, K. Bardhan et al., Changing Patterns of Helicobacter pylori Gastritis in Long-Standing Acid Suppression, Helicobacter, vol.45, issue.4, pp.206-220, 2000.
DOI : 10.1007/s004280050171

P. Correa, E. Fontham, J. Bravo, L. Bravo, B. Ruiz et al., Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy, Journal of the National Cancer Institute, vol.92, issue.23, pp.1881-1889, 2000.
DOI : 10.1093/jnci/92.23.1881

R. Harvey, J. Lane, P. Nair, M. Egger, I. Harvey et al., Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project, Alimentary Pharmacology & Therapeutics, vol.95, issue.3, pp.394-400, 2010.
DOI : 10.1111/j.1365-2036.2007.03500.x

URL : https://hal.archives-ouvertes.fr/hal-00552576

D. Vaira, P. Malfertheiner, F. Mégraud, A. Axon, M. Deltenre et al., Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay, The Lancet, vol.354, issue.9172, pp.30-33, 1999.
DOI : 10.1016/S0140-6736(98)08103-3

B. Schenk, E. Kuipers, G. Nelis, E. Bloemena, J. Thijs et al., Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy, Gut, vol.46, issue.5, pp.615-636, 2000.
DOI : 10.1136/gut.46.5.615

B. Qian, S. Ma, L. Shang, J. Qian, and G. Zhang, Effects of Helicobacter pylori Eradication on Gastroesophageal Reflux Disease, Helicobacter, vol.17, issue.7, pp.255-65, 2011.
DOI : 10.1016/0197-2456(95)00134-4

A. Ruskoné-fourmestraux, W. Fischbach, B. Aleman, H. Boot, M. Du et al., Gastric extranodal marginal zone B-cell lymphoma of MALT, EGILS consensus report Gut. juin, vol.60, issue.6, pp.747-58, 2011.

D. Leest, H. Steen, K. Lems, W. Bijlsma, J. Van-de-laar et al., Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long-term NSAID Treatment: Double-Blind, Randomized, Placebo-Controlled Trial, Helicobacter, vol.34, issue.5, pp.477-85, 2007.
DOI : 10.1056/NEJMe020153

W. Leung, S. Lin, J. Ching, K. To, E. Ng et al., Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication, Gut, vol.53, issue.9, pp.1244-1253, 2004.
DOI : 10.1136/gut.2003.034629

J. Wang, L. Xu, R. Shi, X. Huang, S. Li et al., Gastric Atrophy and Intestinal Metaplasia before and after <i>Helicobacter pylori</i> Eradication: A Meta-Analysis, Digestion, vol.99, issue.4, pp.253-60, 2011.
DOI : 10.1111/j.1572-0241.2004.40948.x

D. Vries, A. Van-grieken, N. Looman, C. Casparie, M. De-vries et al., Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands, Gastroenterology, vol.134, issue.4, pp.945-52, 2008.
DOI : 10.1053/j.gastro.2008.01.071

C. Howden and R. Hunt, Guidelines for the management of Helicobacter pylori infection, The American Journal of Gastroenterology, vol.113, issue.1, pp.2330-2338, 1998.
DOI : 10.1016/S0016-5085(97)80014-5

D. Corley, A. Kubo, T. Levin, G. Block, L. Habel et al., and Gastroesophageal Reflux Disease: A Case-Control Study, Helicobacter, vol.30, issue.Suppl. 1, pp.352-60, 2008.
DOI : 10.1093/oxfordjournals.bmb.a011663

B. Wong, S. Lam, and W. Wong, Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China, JAMA, vol.291, issue.2, pp.187-94, 2004.
DOI : 10.1001/jama.291.2.187

E. El-omar, K. Oien, A. El-nujumi, D. Gillen, A. Wirz et al., Helicobacter pylori infection and chronic gastric acid hyposecretion, Gastroenterology, vol.113, issue.1, pp.15-24, 1997.
DOI : 10.1016/S0016-5085(97)70075-1

F. Chan, J. Ching, and B. Suen, H. pylori eradication on the long-term incidence of recurrent ulcer bleeding in high-tisk aspirin users: a 10-year prospective cohort study, Gastroenterology, vol.140, pp.173-177, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00614345

M. Yaghoobi, F. Farrokhyar, Y. Yuan, and R. Hunt, Is There an Increased Risk of GERD After Helicobacter pylori Eradication?: A Meta-Analysis, The American Journal of Gastroenterology, vol.10, issue.5, pp.1007-1020, 1014.
DOI : 10.1046/j.1365-2036.2000.00677.x

K. Lai, S. Lam, K. Chu, B. Wong, W. Hui et al., Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication, N Engl J Med. 27 juin J Clin Oncol. 11 janv, vol.34623, issue.2631, pp.8018-8042, 2002.

E. Klinkenberg-knol, F. Nelis, J. Dent, P. Snel, B. Mitchell et al., Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa, Gastroenterology, vol.118, issue.4, pp.661-670, 2000.
DOI : 10.1016/S0016-5085(00)70135-1

A. Stathis, C. Chini, F. Bertoni, I. Proserpio, C. Capella et al., Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type, Annals of Oncology, vol.56, issue.12, pp.1086-93, 2009.
DOI : 10.1136/gut.2006.096420

G. Maconi, M. Sainaghi, M. Molteni, M. Bosani, S. Gallus et al., Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication ??? a 7-year follow-up study, European Journal of Gastroenterology & Hepatology, vol.21, issue.4, pp.387-93, 2009.
DOI : 10.1097/MEG.0b013e3283069db0

C. Hawkey, Z. Tulassay, L. Szczepanski, C. Van-rensburg, A. Filipowicz-sosnowska et al., Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study, The Lancet, vol.352, issue.9133, pp.1016-1037, 1998.
DOI : 10.1016/S0140-6736(98)04206-8

F. Chan, J. Sung, S. Chung, K. To, M. Yung et al., Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers, The Lancet, vol.350, issue.9083, pp.975-984, 1997.
DOI : 10.1016/S0140-6736(97)04523-6

A. Wotherspoon, C. Doglioni, T. Diss, L. Pan, A. Moschini et al., Regression of primary low-grade B-cell gastric lymphoma of mucosaassociated lymphoid tissue type after eradication of Helicobacter pylori Relationship between Helicobacter pylori infection and esophageal neoplasia: a metaanalysis, 575?7. 83. Rokkas T, pp.1413-1420, 1993.

O. Connor and H. , Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management, Alimentary Pharmacology and Therapeutics, vol.110, issue.2, pp.117-144, 1999.
DOI : 10.1053/gast.1996.v110.pm8566598

P. Moayyedi, The health economics of Helicobacter pylori infection, Best Practice & Research Clinical Gastroenterology, vol.21, issue.2, pp.347-61, 2007.
DOI : 10.1016/j.bpg.2006.11.004

S. Ikenberry, M. Harrison, D. Lichtenstein, J. Dominitz, M. Anderson et al., The role of endoscopy in dyspepsia, Gastrointestinal Endoscopy, vol.66, issue.6, pp.1071-1076, 2007.
DOI : 10.1016/j.gie.2007.07.007

P. Moayyedi and A. Axon, The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease, The American Journal of Gastroenterology, vol.92, issue.11, pp.3122-3127, 1999.
DOI : 10.1016/S0002-9270(98)80009-9

N. Chiba, S. Van-zanten, P. Sinclair, R. Ferguson, S. Escobedo et al., Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial, BMJ, vol.324, issue.7344, p.1012, 2002.
DOI : 10.1136/bmj.324.7344.1012

J. Gisbert and J. Pajares, 13C-urea breath test in the management of Helicobacter pylori infection, Digestive and Liver Disease, vol.37, issue.12, pp.899-906, 2005.
DOI : 10.1016/j.dld.2005.09.006

A. Asfeldt, M. Løchen, B. Straume, S. Steigen, J. Florholmen et al., Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection, Scandinavian Journal of Gastroenterology, vol.42, issue.2, pp.1073-1080, 2004.
DOI : 10.1128/JCM.42.3.1319-1321.2004

A. Kokkola, H. Rautelin, P. Puolakkainen, P. Sipponen, M. Färkkilä et al., Positive Result by Serology Indicates ActiveHelicobacter pylori Infection in Patients with Atrophic Gastritis, J Clin Microbiol. 6 janv, vol.36, issue.6, pp.1808-1818, 1998.

J. Gisbert, J. Pajares, D. Graham, A. Opekun, F. Hammoud et al., Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection?a critical review Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors, Aliment Pharmacol Ther. Am J Gastroenterol. mai, vol.20, issue.985, pp.1005-1014, 2003.

P. Lehours, A. Ruskone-fourmestraux, A. Lavergne, F. Cantet, and F. Mégraud, Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma?, The American Journal of Gastroenterology, vol.108, issue.2, pp.291-296, 2003.
DOI : 10.1002/(SICI)1096-9896(199808)185:4<409::AID-PATH121>3.0.CO;2-T

N. Dyspepsia, Second consultation, NICE guideline

W. Smellie, D. Wilson, C. A. Mcnulty, M. Galloway, G. Spickett et al., Best practice in primary care pathology: review 1, Journal of Clinical Pathology, vol.58, issue.10, pp.1016-1040, 2005.
DOI : 10.1136/jcp.2004.025049

R. Jones, C. Tait, G. Sladen, and J. Weston-baker, A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice, Int J Clin Pract. sept, vol.53, issue.6, pp.413-419, 1999.

A. El-nujumi, T. Hilditch, C. Williams, and K. Mccoll, Current or recent proton pump inhibitor therapy markedly impairs the accuracy of the [14C]urea breath test, European Journal of Gastroenterology & Hepatology, vol.10, issue.9, pp.759-64, 1998.
DOI : 10.1097/00042737-199809000-00006

J. Gisbert and J. Pajares, Diagnosis of Helicobacter pylori infection by stool antigen determination: a systematic review, The American Journal of Gastroenterology, vol.118, issue.1, pp.2829-2867, 2001.
DOI : 10.1111/j.1572-0241.2000.02193.x

A. Ford, B. Delaney, D. Forman, and P. Moayyedi, Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients, Cochrane Database Syst Rev, issue.4, p.3840, 2003.

R. Laheij, H. Straatman, J. Jansen, and A. Verbeek, Evaluation of Commercially Available Helicobacter pylori Serology Kits: a Review, J Clin Microbiol. oct, vol.36, issue.10, pp.2803-2812, 1998.

D. Graham, A. Opekun, M. Jogi, Y. Yamaoka, H. Lu et al., False Negative Urea Breath Tests with H2-Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH, Helicobacter, vol.91, issue.1, pp.17-27, 2004.
DOI : 10.1046/j.1365-2036.2002.01169.x

K. Mccoll, L. Murray, D. Gillen, A. Walker, A. Wirz et al., Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia, BMJ, vol.324, issue.7344, p.999, 2002.
DOI : 10.1136/bmj.324.7344.999

P. Moayyedi, S. Soo, J. Deeks, D. Forman, J. Mason et al., Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia, BMJ, vol.321, issue.7262, pp.659-64, 2000.
DOI : 10.1136/bmj.321.7262.659

C. Mcnulty, L. Teare, R. Owen, D. Tompkins, P. Hawtin et al., Test and treat for dyspepsia--but which test? BMJ. 15 janv Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment--Helicobacter pylori positive (CADET-Hp) randomised controlled trial, BMJ. 27 avr, vol.330324, issue.7344, p.1012, 2002.

S. Veldhuyzen-van-zanten, M. Bradette, N. Chiba, D. Armstrong, A. Barkun et al., Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool, Canadian Journal of Gastroenterology, vol.19, issue.5, pp.285-303, 2005.
DOI : 10.1155/2005/674607

N. Chiba, V. Van-zanten, and S. , 13C-Urea breath tests are the noninvasive method of choice for Helicobacter pylori detection, Can J Gastroenterol, vol.13, pp.681-684, 1999.

D. Clinch, A. Banerjee, and G. Ostick, ABSENCE OF ABDOMINAL PAIN IN ELDERLY PATIENTS WITH PEPTIC ULCER, Age and Ageing, vol.13, issue.2, pp.120-123, 1984.
DOI : 10.1093/ageing/13.2.120

L. Zhou, J. Sung, S. Lin, J. Z. Ding, S. Huang et al., A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication, Chin Med J (Engl). janv, vol.116, issue.1, pp.11-15, 2003.

K. Satoh, K. Kimura, T. Takimoto, and K. Kihira, A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori, Helicobacter. déc, vol.3, issue.4, pp.236-276, 1998.

D. Graham, Editorial: Can Therapy Ever Be Denied for Helicobacter pylori Infection?, Gastroenterology, vol.113, issue.6, pp.113-120, 1997.
DOI : 10.1016/S0016-5085(97)80023-6

J. Labenz, A. Blum, E. Bayerdörffer, A. Meining, M. Stolte et al., Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis, Gastroenterology, vol.112, issue.5, pp.1442-1449, 1997.
DOI : 10.1016/S0016-5085(97)70024-6

P. Malfertheiner, F. Megraud, O. Morain, C. Bazzoli, F. El-omar et al., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, vol.56, issue.6, pp.772-81, 2007.
DOI : 10.1136/gut.2006.101634

P. Moayyedi, R. Feltbower, and J. Brown, Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial, The Lancet, vol.355, issue.9216, pp.1665-1674, 2000.
DOI : 10.1016/S0140-6736(00)02236-4

G. Manes, A. Menchise, C. De-nucci, and A. Balzano, Empirical prescribing for dyspepsia, European Journal of Gastroenterology & Hepatology, vol.15, issue.7, p.1118, 2003.
DOI : 10.1097/00042737-200307000-00022

T. Yamada, H. Miwa, T. Fujino, S. Hirai, T. Yokoyama et al., Improvement of Gastric Atrophy After Helicobacter pylori Eradication Therapy, Journal of Clinical Gastroenterology, vol.36, issue.5, pp.405-415, 2003.
DOI : 10.1097/00004836-200305000-00009

V. Deluca, . Jr, A. West, and S. Haque, Long-term Symptom Patterns, Endoscopic Findings, and Gastric Histology in Helicobacter pylori-Infected and -Uninfected Patients, Journal of Clinical Gastroenterology, vol.26, issue.2, pp.106-118, 1998.
DOI : 10.1097/00004836-199803000-00004

F. Cremonini, D. Caro, S. Delgado-aros, and S. , Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease, Alimentary Pharmacology and Therapeutics, vol.1, issue.0, pp.279-89, 2003.
DOI : 10.1016/S0140-6736(00)02236-4

D. Graham, . Nsaids, P. Helicobacter, and . Box, and Pandora's Box, New England Journal of Medicine, vol.347, issue.26, pp.2162-2166, 2002.
DOI : 10.1056/NEJMe020153

J. Holvoet, L. Terriere, W. Van-hee, L. Verbist, and E. Fierens, Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study., Gut, vol.32, issue.7, pp.730-734, 1991.
DOI : 10.1136/gut.32.7.730

S. Gabriel, L. Jaakkimainen, and C. Bombardier, Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis

B. Van-pinxteren, M. Numans, J. Lau, N. De-wit, A. Hungin et al., Short-term treatment of gastroesophageal reflux disease, Journal of General Internal Medicine, vol.160, issue.suppl, pp.755-63, 2003.
DOI : 10.1001/archinte.160.12.1810

L. Laine, C. Bombardier, C. Hawkey, B. Davis, D. Shapiro et al., Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis, Gastroenterology, vol.123, issue.4, pp.1006-1018, 2002.
DOI : 10.1053/gast.2002.36013

D. Graham, A. Opekun, F. Hammoud, Y. Yamaoka, R. Reddy et al., Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors, The American Journal of Gastroenterology, vol.84, issue.5, pp.1005-1014, 2003.
DOI : 10.1046/j.1365-2036.2002.01192.x

E. Kuipers, J. Thijs, and F. Hp, The prevalence of Helicobacter pylori in peptic ulcer disease, Aliment Pharmacol Ther, vol.9, issue.2, pp.59-69, 1995.

W. Chey and B. Wong, American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.11, issue.2, pp.1808-1833, 2007.
DOI : 10.1111/j.1523-5378.2006.00436.x

N. Talley, N. Vakil, E. Ballard, and M. Fennerty, in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.341, issue.15, pp.1106-1117, 1999.
DOI : 10.1056/NEJM199910073411502

L. Gatta, C. Ricci, A. Tampieri, J. Osborn, F. Perna et al., Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial, Gut, vol.55, issue.4, pp.457-62, 2006.
DOI : 10.1136/gut.2005.078626

J. Gisbert, F. De-la-morena, V. Abraira, A. Balzano, G. Iaquinto et al., Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy, 1921?30. 149. Manes G, pp.73-82, 2001.

W. Chey, Accurate Diagnosis of Helicobacter Pylori, Gastroenterology Clinics of North America, vol.29, issue.4, pp.895-902, 2000.
DOI : 10.1016/S0889-8553(05)70157-6

B. Ho and B. Marshall, Accurate Diagnosis of Helicobacter pylori, Gastroenterology Clinics of North America, vol.29, issue.4, pp.853-62, 2000.
DOI : 10.1016/S0889-8553(05)70152-7

W. Chey, U. Murthy, S. Shaw, A. Zawadski, J. Montague et al., A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial, The American Journal of Gastroenterology, vol.540, issue.6, pp.1512-1518, 1999.
DOI : 10.1016/S0002-9270(97)00003-8

B. Gessner, H. Baggett, and P. Muth, A con-trolled, householdrandomized , open-label trial of the effect that treatment of Helicobacter pylori infection has on iron-de fi ciency in children in rural Alaska, J Infect Dis, issue.193, pp.537-583, 2006.

N. Talley and A. Gastroenterological-association, American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia, Gastroenterology, vol.129, issue.5, pp.1753-1758, 2005.
DOI : 10.1053/j.gastro.2005.09.019

A. Leodolter, M. Kulig, and H. Brasch, A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori -associated gastric or duodenal ul-cer, Aliment Pharmacol Ther, issue.15, 2001.

U. Peitz, A. Leodolter, S. Kahl, K. Agha-amiri, T. Wex et al., Antigen stool test for assessment of Helicobacter pylori infection in patients with upper gastrointestinal bleeding, Alimentary Pharmacology and Therapeutics, vol.120, issue.1, pp.1075-84, 2003.
DOI : 10.1016/S0210-5705(01)70125-2

P. Moayyedi, J. Deeks, and N. Talley, An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews, The American Journal of Gastroenterology, vol.136, issue.2, pp.2621-2627, 2003.
DOI : 10.1136/gut.48.6.759

W. Chey, D. Metz, S. Shaw, D. Kearney, J. Montague et al., Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infection, The American Journal of Gastroenterology, vol.38, issue.5, pp.1171-1175, 2000.
DOI : 10.1016/S0002-9270(99)00341-X

P. Griñó, S. Pascual, J. Such, J. Casellas, M. Niveiro et al., Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper-gastrointestinal bleeding of peptic origin, European Journal of Gastroenterology & Hepatology, vol.15, issue.5, pp.525-534, 2003.
DOI : 10.1097/01.meg.0000059114.41030.a9

C. Loy, L. Irwig, P. Katelaris, and N. Talley, Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis, Am J Gastroenterol. juin, vol.91, issue.6, pp.1138-1182, 1996.

D. Mcnamara, M. Buckley, and J. Gilvarry, Does He-licobacter pylori eradication affect symptoms in nonulcer dyspepsia: A 5-year follow-up study, Helicobacter, issue.7, pp.317-338, 2002.

L. Laine and J. Sugg, Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies, The American Journal of Gastroenterology, vol.35, issue.12, pp.2992-2999, 2002.
DOI : 10.1067/mge.2002.122617

L. Bravo, J. Realpe, C. Campo, R. Mera, and P. Correa, Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection, The American Journal of Gastroenterology, vol.107, issue.9, pp.2380-2383, 1999.
DOI : 10.1016/S0140-6736(87)90664-7

G. Paptheodoridis, S. Sougioultzis, and A. Archimandritis, Effects of Helicobacter pylori and nonsteroidal anti-in fl ammatory drugs on peptic ulcer disease: A sys-tematic review, Clin Gastroenterol Hepatol, issue.4, pp.130-172, 2006.

H. Baggett, A. Parkinson, P. Muth, B. Gold, and B. Gessner, Endemic Iron Deficiency Associated With Helicobacter pylori Infection Among School-Aged Children in Alaska, PEDIATRICS, vol.117, issue.3, pp.396-404, 2006.
DOI : 10.1542/peds.2005-1129

L. Laine, J. Sugg, L. Suchower, and G. Neil, Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori, Gastrointestinal Endoscopy, vol.51, issue.6, pp.664-673, 2000.
DOI : 10.1067/mge.2000.105776

T. Hoang, T. Wheeldon, C. Bengtsson, D. Phung, M. Sörberg et al., Enzyme-Linked Immunosorbent Assay for Helicobacter pylori Needs Adjustment for the Population Investigated, Journal of Clinical Microbiology, vol.42, issue.2, pp.627-657, 2004.
DOI : 10.1128/JCM.42.2.627-630.2004

P. Moayyedi, S. Soo, J. Deeks, B. Delaney, A. Harris et al., Eradication of Helicobacter pylori for non-ulcer dyspepsia, Cochrane Database Syst Rev, issue.1, p.2096, 2005.

P. Hsu, K. Lai, and H. Tseng, Eradication of Heli-cobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia, Aliment Pharmacol Ther, issue.15, pp.195-201, 2001.

J. Gilvarry, M. Buckley, and S. Beattie, Eradication of H. pylori affects symptoms in non-ulcer dyspepsia

A. Ford, B. Delaney, D. Forman, and P. Moayyedi, Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis, The American Journal of Gastroenterology, vol.312, issue.2, pp.1833-55, 2004.
DOI : 10.1136/bmj.312.7027.349

F. Ahmed, U. Murthy, W. Chey, P. Toskes, D. Wagner et al., Evaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication, Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy, 2005.
DOI : 10.1002/bms.1200111103

N. Talley and N. Vakil, Guidelines for the Management of Dyspepsia, The American Journal of Gastroenterology, vol.10, issue.1, pp.2324-2361, 2005.
DOI : 10.1111/j.1365-2982.2004.00516.x

C. Howden and R. Hunt, Guidelines for the manage-ment of Helicobacter pylori infection, Am J Gastroenterol, issue.93, pp.2330-2338, 1998.

P. Farinha and R. Gascoyne, Helicobacter pylori and MALT Lymphoma, Gastroenterology, vol.128, issue.6, pp.1579-605, 2005.
DOI : 10.1053/j.gastro.2005.03.083

F. Perri, G. Manes, M. Neri, D. Vaira, and G. Nardone, Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments, The American Journal of Gastroenterology, vol.97, issue.11
DOI : 10.1111/j.1572-0241.2002.07065.x

C. Ley, A. Mohar, J. Guarner, R. Herrera-goepfert, L. Figueroa et al., Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.1, pp.4-10, 2004.
DOI : 10.1158/1055-9965.EPI-03-0124

P. Malfertheiner, M. ?. , J. Fischbach, and W. , Helicobac-ter pylori eradication is bene fi cial in the treatment of func-tional dyspepsia

V. Sharma, A. Sahai, and F. Corder, Helicobacter py-lori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage

H. Lin, W. Lo, C. Perng, A. Li, G. Tseng et al., Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers, Helicobacter, vol.19, issue.3, pp.663-671, 2004.
DOI : 10.1097/00042737-200104000-00013

F. Mégraud and B. Marshall, How to Treat Heliobacter pylori, Gastroenterology Clinics of North America, vol.29, issue.4, pp.759-73, 2000.
DOI : 10.1016/S0889-8553(05)70145-X

J. Pandolfino, C. Howden, and P. H. Kahrilas, H. Pylori and GERD: Is Less More?, The American Journal of Gastroenterology, vol.84, issue.7, pp.1222-1227, 2004.
DOI : 10.1111/j.1572-0241.2000.01970.x

J. Gisbert, S. Khorrami, and F. Carballo, pylori erad-ication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory ther-apy) for the prevention of recurrent bleeding from peptic ulcer, Cochrane Database Syst Rev, 2004.

A. Hacihanefioglu, F. Edebali, A. Celebi, T. Karakaya, O. Senturk et al., Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori, Hepatogastroenterology. févr, vol.51, issue.55, pp.313-318, 2004.

V. Cardenas, Z. Mulla, M. Ortiz, and D. Graham, Iron Deficiency and Helicobacter pylori Infection in the United States, American Journal of Epidemiology, vol.163, issue.2, pp.127-161, 2006.
DOI : 10.1146/annurev.nutr.22.120501.134539

M. Van-leerdam, A. Van-der-ende, F. Kate, E. Rauws, and G. Tytgat, Lack of accuracy of the noninvasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding, The American Journal of Gastroenterology, vol.24, issue.2, pp.798-801, 2003.
DOI : 10.1136/adc.83.3.268

A. Blum, N. Talley, O. Moráin, C. Van-zanten, S. Labenz et al., Infection in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.339, issue.26, pp.1875-81, 1998.
DOI : 10.1056/NEJM199812243392602

T. Wundisch, C. Thiede, and A. Morgner, Long-term follow-up gastric MALT lymphoma after Helicobacter py-lori eradication, J Clin Oncol, issue.23, pp.8018-8042, 2001.

R. Mera, E. Fontham, L. Bravo, J. Bravo, M. Piazuelo et al., Long term follow up of patients treated for Helicobacter pylori infection, Gut, vol.54, issue.11, pp.1536-1576, 2005.
DOI : 10.1136/gut.2005.072009

L. Chen, J. Lin, and J. Tai, Long-term results of anti-Helicobacter pylori therapy in early-stage gastric highgrade transformed MALT lymphoma, J Natl Cancer Inst, issue.97, pp.1345-53, 2005.

C. Liu, C. Lee, C. Chan, T. Tu, C. Liao et al., Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer, Archives of Internal Medicine, vol.163, issue.17, pp.2020-2024, 2003.
DOI : 10.1001/archinte.163.17.2020

F. Cremonini, D. Caro, S. Delgado-aros, and S. , Meta-analysis: The relationship between Helicobacter pylori infection and gastrooesophageal re fl ux disease, Aliment Pharmacol Ther, issue.18, pp.279-89, 2003.

W. Chey and A. Fendrick, Noninvasive Helicobacter pylori Testing for the "Test-and-Treat" Strategy, Archives of Internal Medicine, vol.161, issue.17, pp.2129-2161, 2001.
DOI : 10.1001/archinte.161.17.2129

F. Chan, NSAID-Induced Peptic Ulcers and Helicobacter pylori Infection, Drug Safety, vol.17, issue.9, pp.287-300, 2005.
DOI : 10.2165/00002018-200528040-00002

N. Vakil, N. Talley, and M. Stolte, Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal re fl ux disease in Western patients with non-ulcer dyspepsia, Aliment Pharmacol, issue.24, pp.55-63, 2006.

Z. Nurgalieva, D. Graham, A. Raghunath, A. Hungin, D. Wooff et al., Pearls and pitfalls of assessing Helicobacter pylori status Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver Prevalence of Helicobacter pylori in patients with gastrooesophageal reflux disease: systematic review, juin BMJ. 5 avr, vol.35326, issue.67392, p.737, 2003.

S. Eswaran, J. Scheiman, and C. Howden, Primary care physician perceptions of non-steroidal anti-in fl ammatory drug and aspirin-associated toxicity: Results of a national survey

Y. Choe, S. Kim, B. Son, D. Lee, Y. Hong et al., Randomized Placebo-Controlled Trial of Helicobacter pylori Eradication for Iron-Deficiency Anemia in Preadolescent Children and Adolescents, Helicobacter, vol.34, issue.2, pp.135-144, 1999.
DOI : 10.1146/annurev.me.34.020183.000415

J. Everhart, RECENT DEVELOPMENTS IN THE EPIDEMIOLOGY OF HELICOBACTER PYLORI, Gastroenterology Clinics of North America, vol.29, issue.3, pp.559-78, 2000.
DOI : 10.1016/S0889-8553(05)70130-8

T. Steen, K. Berstad, T. Meling, and A. Berstad, Reproducibility of the 14C urea breath test repeated after 1 week, Am J Gastroenterol. déc, vol.90, issue.12, pp.2103-2108, 1995.

B. Annibale, M. Marignani, B. Monarca, G. Antonelli, A. Marcheggiano et al., Eradication in Patients with Asymptomatic Gastritis, Annals of Internal Medicine, vol.131, issue.9, pp.668-72, 1999.
DOI : 10.7326/0003-4819-131-9-199911020-00006

J. Gisbert and J. Pajares, Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review, Alimentary Pharmacology and Therapeutics, vol.15, issue.3, pp.1001-1018, 2004.
DOI : 10.1111/j.1083-4389.2004.00191.x

P. Hsu, K. Lai, G. Lo, H. Tseng, C. Lo et al., Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients, Gut, vol.51, issue.1, pp.15-20, 2002.
DOI : 10.1136/gut.51.1.15

G. Papatheodoridis and A. Archimandritis, Role of Heli-cobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users, pp.3811-3817, 2005.

T. Schaeverbeke, N. Broutet, F. Zerbib, B. Combe, P. Bertin et al., Should We Eradicate Helicobacter pylori Before Prescribing an NSAID? Result of a Placebo-Controlled Study, The American Journal of Gastroenterology, vol.29, issue.6
DOI : 10.1136/gut.51.3.329

J. Sung, Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Aliment Pharma-Col Ther, pp.65-70, 2004.

J. Gisbert and J. Pajares, Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: a Systematic Review, Helicobacter, vol.47, issue.4, pp.347-68, 2004.
DOI : 10.1046/j.1365-2036.2001.00106.x

K. Mccoll, L. Murray, and E. El-omar, Symptomatic bene fi t from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia, N Engl J Med, issue.339, pp.1869-74, 1998.

A. Raghunath, A. Hungin, and D. Wooff, Systematic review: The effect of Helicobacter pylori and its eradication on gastro-oesophageal re fl ux disease in patients with duodenal ulcers or re fl ux oesophagitis, Aliment Pharmacol Ther, issue.20, pp.733-777, 2004.

W. Chey, U. Murthy, P. Toskes, S. Carpenter, and L. Laine, The 13C-urea blood test accurately detects active Helicobacter pylori infection: a United States, multicenter trial, The American Journal of Gastroenterology, vol.123, issue.6, pp.1522-1526, 1999.
DOI : 10.7326/0003-4819-123-4-199508150-00003

N. Vakil, D. Rhew, A. Soll, and J. Ofman, The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori, The American Journal of Gastroenterology, vol.319, issue.8, pp.1691-1699, 2000.
DOI : 10.1046/j.1365-2036.2000.00677.x

T. Kamada, K. Haruma, and J. Hata, The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundi atrophic gastritis, Aliment Pharmacol Ther, issue.18, pp.245-52, 2003.

D. Vaira, N. Vakil, M. Menegatti, B. Van-'t-hoff, C. Ricci et al., after Eradication Therapy, Annals of Internal Medicine, vol.136, issue.4, pp.280-287, 2002.
DOI : 10.7326/0003-4819-136-4-200202190-00007

C. Montalban and F. Norman, Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter py-lori eradication and beyond, Expert Rev Anticancer Ther, issue.6, pp.361-71, 2006.

N. Wit, W. Boer, H. Geldof, B. Hazelhoff, P. Bergmans et al., Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?, Alimentary Pharmacology and Therapeutics, vol.98, issue.4, pp.451-459, 2004.
DOI : 10.1016/S1590-8658(01)80100-6

M. Güell, E. Artigau, V. Esteve, J. Sánchez-delgado, F. Junquera et al., Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer, Alimentary Pharmacology and Therapeutics, vol.40, issue.1, pp.53-62, 2006.
DOI : 10.1053/j.gastro.2003.11.006

A. Leodolter, J. Domínguez-muñoz, U. Von-arnim, S. Kahl, U. Peitz et al., Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting, The American Journal of Gastroenterology, vol.92, issue.2, pp.2100-2104, 1999.
DOI : 10.1042/cs0930003

P. Malfertheiner, F. Mégraud, O. Morain, C. Hungin, A. Jones et al., Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report, Alimentary Pharmacology and Therapeutics, vol.13, issue.2, pp.167-80, 2002.
DOI : 10.1128/JCM.39.1.394-397.2001

M. Caselli, A. Zullo, G. Maconi, F. Parente, V. Alvisi et al., guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy, Cervia II Working Group Report Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. août, vol.39, issue.8, pp.782-791, 2006.

G. Manes, M. Zanetti, M. Piccirillo, G. Lombardi, A. Balzano et al., Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study, 751?5. 223. Schilling D, pp.217-238, 2003.

C. Scarpignato, Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, juill, vol.37, issue.7, pp.468-74, 2005.

M. Caselli, F. Parente, D. Palli, A. Covacci, V. Alvisi et al., ???Cervia Working Group Report???: Guidelines on the diagnosis and treatment of Helicobacter pylori infection, Digestive and Liver Disease, vol.33, issue.1, pp.75-80, 2001.
DOI : 10.1016/S1590-8658(01)80139-0

A. Andriani, A. Zullo, D. Raimondo, F. Patti, C. Tedeschi et al., Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study, Alimentary Pharmacology and Therapeutics, vol.20, issue.6, pp.721-727, 2006.
DOI : 10.3748/wjg.v11.i15.2354

X. Calvet, M. Quesada, I. Sanfeliu, F. Salceda, M. Roselló et al., Diagnosis of Helicobacter pylori infection in dyspeptic patients by stool antigen detection usefulness of a new monoclonal enzyme immunoassay test, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. juill, vol.36, issue.7, pp.450-454, 2004.

D. Antos, J. Crone, N. Konstantopoulos, and S. Koletzko, Evaluation of a Novel Rapid One-Step Immunochromatographic Assay for Detection of Monoclonal Helicobacter pylori Antigen in Stool Samples from Children, Journal of Clinical Microbiology, vol.43, issue.6, pp.2598-601, 2005.
DOI : 10.1128/JCM.43.6.2598-2601.2005

D. Koster, E. , D. Bruyne, I. Langlet, P. Deltenre et al., Evidence based medicine and extradigestive manifestations of Helicobacter pylori):388?92. 230. Smith ML. Functional dyspepsia pathogenesis and therapeutic options-implications for management, Acta Gastro- Enterol Belg. déc Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. août, vol.6337, issue.48, pp.547-58, 2000.

D. Vaira, L. Gatta, C. Ricci, D. Anna, L. Miglioli et al., Helicobacter pylori: diseases, tests and treatment, Digestive and Liver Disease, vol.33, issue.9, pp.788-94, 2001.
DOI : 10.1016/S1590-8658(01)80697-6

P. Malfertheiner, Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease, Gut, vol.53, issue.2, pp.312-315, 2004.
DOI : 10.1136/gut.2003.019836

URL : http://gut.bmj.com/content/gutjnl/53/2/312.full.pdf

C. Ciacci, F. Sabbatini, R. Cavallaro, F. Castiglione, D. Bella et al., Helicobacter pylori impairs iron absorption in infected individuals, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. juill, vol.36, issue.7, pp.455-60, 2004.

F. Parente, S. Bargiggia, and A. Anderloni, infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: A liaison dangereuse or an innocent interplay?, Scandinavian Journal of Gastroenterology, vol.21, issue.10, pp.1121-1126, 2006.
DOI : 10.1111/j.1365-2036.2005.02368.x

K. Fujimura, Helicobacter pylori Infection and Idiopathic Thrombocytopenic Purpura, International Journal of Hematology, vol.158, issue.2, pp.113-121, 2005.
DOI : 10.1532/IJH97.04161

N. Uemura, S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi et al., Infection and the Development of Gastric Cancer, New England Journal of Medicine, vol.345, issue.11, pp.784-793, 2001.
DOI : 10.1056/NEJMoa001999

A. Pilotto, M. Franceschi, M. Longoa, C. Scarcelli, G. Orsitto et al., Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin, Digestive and Liver Disease, vol.36, issue.10, pp.666-70, 2004.
DOI : 10.1016/j.dld.2004.05.011

A. Zullo, C. Hassan, and S. Morini, Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, mars, vol.35, issue.3, pp.197-205, 2003.

C. Doglioni, A. Wotherspoon, A. Moschini, M. De-boni, and P. Isaacson, High incidence of primary gastric lymphoma in northeastern Italy, The Lancet, vol.339, issue.8797, pp.834-839, 1992.
DOI : 10.1016/0140-6736(92)90280-G

A. Hirschl and A. Makristathis, Noninvasive Helicobacter pylori diagnosis: stool or breath tests? Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, oct, vol.37, issue.10, pp.732-736, 2005.

C. Hawkey, Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?, Alimentary Pharmacology and Therapeutics, vol.124, issue.s2, pp.59-64, 2004.
DOI : 10.1136/gut.52.1.16

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2004.02042.x/pdf

F. Parente, A. Anderloni, S. Bargiggia, V. Imbesi, E. Trabucchi et al., Outcome of non-variceal acute upper gastrointestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: A two-year survey, World Journal of Gastroenterology, vol.11, issue.45, pp.7122-7152, 2005.
DOI : 10.7326/0003-4819-139-4-200308190-00005

A. Pilotto, M. Franceschi, G. Leandro, F. Paris, L. Cascavilla et al., Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs, Alimentary Pharmacology and Therapeutics, vol.19, issue.10, pp.1091-1098, 2004.
DOI : 10.1046/j.1365-2036.2000.00804.x

W. You, L. Brown, L. Zhang, J. Li, J. M. Chang et al., Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions, JNCI: Journal of the National Cancer Institute, vol.98, issue.14, pp.974-83, 2006.
DOI : 10.1016/S0140-6736(04)17138-9

D. Vaira, L. Gatta, C. Ricci, and M. Miglioli, infection, Alimentary Pharmacology & Therapeutics, vol.95, issue.1, pp.16-23, 2002.
DOI : 10.1016/S0016-5085(01)80248-1

URL : https://hal.archives-ouvertes.fr/hal-00464770

P. Sharma and N. Vakil, Helicobacter pylori and reflux disease, Alimentary Pharmacology and Therapeutics, vol.19, issue.6, pp.297-305, 2003.
DOI : 10.1016/S0016-5085(98)70364-6

F. Chan and D. Graham, A Review Article, India Quarterly: A Journal of International Affairs, vol.129, issue.1, pp.1051-61, 2004.
DOI : 10.1177/097492848504100131

R. Hunt and F. Bazzoli, Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing
DOI : 10.1111/j.0953-0673.2004.01830.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.0953-0673.2004.01830.x/pdf

J. Sung, Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?, Alimentary Pharmacology and Therapeutics, vol.39, issue.s2, pp.65-70, 2004.
DOI : 10.1046/j.1440-1746.2000.02267.x

D. Vaira, L. Gatta, and C. Ricci, Stool test for Helicobacter pylori. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, juill, vol.36, issue.7, pp.446-453, 2004.

N. Abraham, P. Moayyedi, B. Daniels, V. Van-zanten, and S. , The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia, Alimentary Pharmacology and Therapeutics, vol.40, issue.3, pp.631-672, 2004.
DOI : 10.1046/j.1365-2036.2002.01373.x

B. Annibale, G. Capurso, D. Fave, and G. , The stomach and iron deficiency anaemia: a forgotten link. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, avr, vol.35, issue.4, pp.288-95, 2003.

M. Orengo, C. Casella, V. Fontana, R. Filiberti, M. Conio et al., Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986.

L. Ibáñez, X. Vidal, L. Vendrell, U. Moretti, and J. Laporte, Upper gastrointestinal bleeding associated with antiplatelet drugs, Alimentary Pharmacology and Therapeutics, vol.12, issue.56, pp.235-277, 2006.
DOI : 10.1161/01.STR.0000063141.24491.50

D. Henry, L. Lim, G. Rodriguez, L. , P. Gutthann et al., Variability in risk of gastrointestinal complications with individual non-steroidal antiinflammatory drugs: results of a collaborative meta-analysis, BMJ. 22 juin, vol.312, issue.7046, pp.1563-1569, 1996.

C. Musumba, A. Jorgensen, L. Sutton, D. Van-eker, J. Moorcroft et al., The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010, Alimentary Pharmacology & Therapeutics, vol.36, issue.Suppl. 12, pp.48-56, 2005.
DOI : 10.1016/S0889-8553(05)70152-7

A. Ford, Eradicating Helicobacter Pylori in Functional Dyspepsia, Gastroenterology, vol.142, issue.7, pp.1613-1617, 2012.
DOI : 10.1053/j.gastro.2012.04.022

A. Raghunath, A. Hungin, J. Mason, and W. Jackson, Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized-controlled trial, Alimentary Pharmacology & Therapeutics, vol.90, issue.Suppl. 3, pp.585-92, 2007.
DOI : 10.1136/bmj.317.7156.452

A. Duggan, C. Elliott, P. Miller, C. Hawkey, and R. Logan, testing and empirical therapy for the management of dyspepsia in primary care, Alimentary Pharmacology & Therapeutics, vol.336, issue.Suppl, pp.55-68, 2009.
DOI : 10.1017/CBO9780511625817.005

A. Lanas, J. Goldstein, F. Chan, C. Wilcox, D. Peura et al., Risk factors associated with a decrease ???2??g/dL in haemoglobin and/or ???10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR), Alimentary Pharmacology & Therapeutics, vol.165, issue.Suppl. 1, pp.485-92, 2012.
DOI : 10.1001/archinte.165.19.2214

A. Uyaniko?lu, A. Danalio?lu, F. Akyüz, F. Erm??, M. Güllüo?lu et al., Etiological factors of duodenal and gastric ulcers, The Turkish Journal of Gastroenterology, vol.23, issue.2, pp.99-103, 2012.
DOI : 10.4318/tjg.2012.0435

D. Elios, M. Silvestri, E. Emmi, G. Zilevica, A. Prisco et al., Helicobacter pylori management in primary care, Intern Emerg Med. août, vol.7, issue.4, pp.297-305, 2012.

H. Nafil, I. Tazi, M. Sifessalam, M. Bouchtia, and L. Mahmal, L'anémie par carence en vitamine B12 dans la région de Marrakech (Maroc) Rev DÉpidémiologie Santé Publique, févr, vol.61, issue.1, pp.78-81, 2013.
DOI : 10.1016/j.respe.2012.07.003

K. Holmes, J. Fang, and B. Jackson, Cost-effectiveness of six strategies for Helicobacter pyloridiagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern, BMC Health Services Research, vol.11, issue.3, p.344, 2010.
DOI : 10.1002/14651858.CD002096.pub4

A. Musana, S. Yale, and K. Lang, Managing Dyspepsia in a Primary Care Setting, Clinical Medicine & Research, vol.4, issue.4, pp.337-379, 2006.
DOI : 10.3121/cmr.4.4.337

. Helicobacter-pylori-et-cancer-gastrique, C. Li, L. Simon, G. Singh, M. Stillman et al., Disponible sur: http://www.inserm.fr/actualites/rubri ques/actualites- recherche/helicobacter-pylori-et- cancer-gastrique-un-des-mecanismes- elucide 268. afssaps, recommandations de bonnes pratiques: les antisécrétoires gastriques chez l'adulte [Internet]. [cité 8 oct 2013] Disponible sur: http://www.ansm.sante.fr/var/ansm_ site/storage/original/application/4eab 9fc78eba0b7b11e4fb6543dd65e2 GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial time: an analysis of two large outcome trials, Am J Gastroenterol. mars Aliment Pharmacol Ther. 1 oct, vol.10834, issue.2707, pp.392-400808, 2011.

G. Holtmann, C. Van-rensburg, T. Schwan, P. Sander, and W. Siffert, Improvement of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal Symptoms during Proton Pump Inhibitor Treatment: Are G-Protein ??3 Subunit Genotype, <i>Helicobacter pylori</i> Status, and Environmental Factors Response Modifiers?, Digestion, vol.67, issue.4, pp.289-98, 2011.
DOI : 10.1136/ard.2008.092015

L. Ki, E. Chan, and F. , Interaction of Helicobacter pylori infection and lowdose aspirin in the upper gastrointestinal tract: Implications for clinical practice, Best Pract Res Clin Gastroenterol. avr, vol.26, issue.2, pp.163-72, 2012.

K. Goh and W. Chan, Commentary: changing aetiology of peptic ulcers, Alimentary Pharmacology & Therapeutics, vol.4, issue.3, pp.291-293, 2012.
DOI : 10.1038/ncpgasthep0769

N. Ljubi?i?, Z. Puljiz, I. Budimir, A. Bi??anin, A. Bratani? et al., The Influence of Etiologic Factors on Clinical Outcome in Patients with Peptic Ulcer Bleeding, Digestive Diseases and Sciences, vol.128, issue.234, pp.3195-204, 2012.
DOI : 10.1053/j.gastro.2005.03.026

G. Nervi, S. Liatopoulou, L. Cavallaro, A. Gnocchi, N. Dal-bo et al., Does Helicobacter pylori infection eradication modify peptic ulcer prevalence A 10 years' endoscopical survey, World Journal of Gastroenterology, vol.12, issue.15, pp.2398-401, 2006.
DOI : 10.1023/A:1012731614075

N. Vakil and A. Fendrick, How to test for Helicobacter pylori in 2005., Cleveland Clinic Journal of Medicine, vol.72, issue.Suppl_2, p.8, 2005.
DOI : 10.3949/ccjm.72.Suppl_2.S8